altRx vs TrimRX
Two value-oriented compounded programs. altRx pushes the entry price down ($89 semaglutide), adds financing, and keeps a brand-name option in reserve. TrimRX competes on flexible plans and ongoing clinical guidance rather than a headline rate.
Last reviewed 2026-09-01 · Pricing is provider-reported and changes often — confirm current rates on each provider's site. We may earn a commission.
Educational, not medical advice. This page explains GLP-1 medications in general terms. Only a licensed clinician who knows your history can decide what's right for you.
altRx's clear, low, financeable pricing and brand-name option make it the safer default; TrimRX is for those who value ongoing guidance over price certainty.
View Plan: altRxChoose altRx if…
price, financing, and the option to switch to brand-name matter most.
Choose TrimRX if…
you want flexible plans with ongoing clinical support.
Cost breakdown
The numbers that actually decide it, side by side.
| | |
|---|---|---|
| Semaglutide, monthly | $89/mo | Competitive (confirm current plan) |
| GLP-1 + GIP, monthly | From $149/mo | Compounded (plan-dependent) |
| Financing | Buy Now, Pay Later | — |
| Brand-name option | Yes — Wegovy, Zepbound | No |
| Ongoing guidance | Standard follow-up | Emphasized throughout |
altRx gives you a number you can anchor on — $89/mo compounded semaglutide, $149/mo for the GLP-1/GIP option — plus Buy Now, Pay Later if cash flow is tight. Over six months of semaglutide that's about $534, and you keep the option to move to brand-name Wegovy/Zepbound without switching providers.
TrimRX doesn't lead with a single price; it bundles ongoing clinical guidance into flexible plans. For someone who wants more support and expects to adjust their plan, that structure can be worth more than shaving a few dollars off the monthly rate.
Net: altRx for price certainty, financing and a brand off-ramp; TrimRX for a more guided, adjustable experience.
Full specs, side by side
| | |
|---|---|---|
| Starting price | $89/mo (compounded semaglutide) | Competitive (varies by plan — not a single flat number) |
| Compounded semaglutide | $89/mo (compounded) | Compounded (plan-dependent) |
| Tirzepatide | From $149/mo (compounded GLP-1 + GIP) | Compounded (plan-dependent) |
| GLP-1 + GIP option | Yes — compounded tirzepatide (GLP-1 + GIP) from $149/mo | Yes — compounded tirzepatide (GLP-1/GIP) |
| Offering type | Both | Compounded |
| New-patient offer | Buy Now, Pay Later financing available | Varies by plan |
| Billing model | Monthly plans; multi-month options | Flexible monthly plans |
| What's included | Online medical evaluation, Medication, Shipping, Dose adjustments | Medical evaluation, Medication, Ongoing clinical guidance |
| Lab work | Online intake; labs may be requested for some patients | Online intake; guidance-led follow-up |
| Shipping | Included | Included |
| Refills | Monthly refills | Monthly refills |
| States | Most US states | Most US states |
| Pharmacy | US compounding pharmacies (503A); brand via licensed pharmacies | US compounding pharmacies |
| Clinicians | US-licensed prescribers | US-licensed prescribers |
| Insurance | Cash; Buy Now, Pay Later available | Cash |
| Consultation | Asynchronous online medical intake | Online intake with ongoing clinical guidance |
| Our rating | 9.6 · Excellent | 9.4 · Excellent |
Medications & formulations
- altRx: compounded semaglutide/tirzepatide plus brand-name Wegovy/Zepbound.
- TrimRX: compounded semaglutide and tirzepatide, with ongoing guidance; no brand-name option.
New to the drugs themselves? Read our plain-language guides to semaglutide and tirzepatide.
Pros & cons
Pros
- Lowest published compounded entry price in our list
- Rare option to choose compounded OR brand-name in one place
- Buy Now, Pay Later spreads the cost
- No insurance needed to start
Cons
- Compounded products aren't FDA-approved finished drugs
- Brand-name pricing depends on insurance/eligibility
Pros
- Ongoing clinical guidance, not a one-and-done script
- Both semaglutide and tirzepatide offered
- Flexible, adjustable plans
Cons
- Entry pricing not published as a single flat number
- Compounded only
Where each one has the edge
We don't tally a winner — that hides the trade-offs. Here's who leads on each dimension and why.
altRx publishes a low $89/mo compounded entry.
altRx also offers brand Wegovy/Zepbound; TrimRX is compounded-only.
TrimRX leans into continued clinical guidance.
altRx offers Buy Now, Pay Later.
TrimRX advertises flexible, adjustable plans.
Match by your priority
The fastest way to decide: find your top priority, see which program we'd point you to.
If your priority is You want the lowest entry price
If your priority is You may want brand-name later
If your priority is You value ongoing clinical support
If your priority is You want an adaptable plan
altRx vs TrimRX: common questions
The bottom line
altRx wins on price certainty, financing and optionality; TrimRX wins on guidance and flexibility. If cost and a brand off-ramp matter, altRx; if support is the priority, TrimRX.
How we compare — and how to read this
We compare programs on the factors that actually affect a patient: real price (including whether it's compounded or branded), medications and formulations offered, shipping, pharmacy accreditation and clinician model, insurance stance, and commitment. We name a top pick for most people, but we show the trade-offs in full so you can override it when your priorities or insurance point the other way. Pricing is provider-reported and changes frequently — and compounded-drug availability shifts with FDA shortage status — so always confirm the current details on the provider's own site before enrolling. Affiliate relationships do not change a program's placement. This page is educational and not medical advice; see our disclaimer.